New York State Common Retirement Fund Macrogenics Inc Transaction History

New York State Common Retirement Fund

$74.6 Billion
Q4 2024

A detailed history of New York State Common Retirement Fund transactions in Macrogenics Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 5,244 shares of MGNX stock, worth $8,495. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,244

Previous 5,244 -0.0%

Holding current value

$8,495

Previous $17,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$3.0 - $5.55 $54,600 - $101,010	-18,200 Reduced 77.63%	5,244 $17,000
Q2 2024 Jul 31, 2024	BUY	$3.31 - $18.51 $903 - $5,053	273 Added 1.18%	23,444 $100,000
Q1 2024 May 07, 2024	BUY	$9.77 - $21.47 $43,740 - $96,121	4,477 Added 23.95%	23,171 $341,000
Q4 2023 Feb 01, 2024	SELL	$4.48 - $10.11 $398 - $899	-89 Reduced 0.47%	18,694 $180,000
Q3 2023 Nov 07, 2023	BUY	$4.48 - $6.19 $904 - $1,250	202 Added 1.09%	18,783 $88,000
Q2 2023 Aug 07, 2023	SELL	$4.62 - $7.54 $221 - $361	-48 Reduced 0.26%	18,581 $99,000
Q1 2023 May 02, 2023	SELL	$4.82 - $7.24 $82,556 - $124,006	-17,128 Reduced 47.9%	18,629 $134,000
Q4 2022 Jan 30, 2023	BUY	$3.34 - $6.98 $27,094 - $56,621	8,112 Added 29.34%	35,757 $240,000
Q3 2022 Nov 08, 2022	BUY	$3.01 - $5.22 $45,800 - $79,427	15,216 Added 122.42%	27,645 $96,000
Q2 2022 Aug 04, 2022	SELL	$2.25 - $9.99 $67,792 - $300,998	-30,130 Reduced 70.8%	12,429 $37,000
Q1 2022 May 05, 2022	SELL	$8.12 - $16.9 $155,075 - $322,756	-19,098 Reduced 30.97%	42,559 $375,000
Q4 2021 Feb 02, 2022	SELL	$15.91 - $21.88 $9,975 - $13,718	-627 Reduced 1.01%	61,657 $990,000
Q3 2021 Nov 02, 2021	SELL	$19.74 - $28.7 $202,690 - $294,691	-10,268 Reduced 14.15%	62,284 $1.3 Million
Q2 2021 Aug 02, 2021	SELL	$20.49 - $35.63 $17,436 - $30,321	-851 Reduced 1.16%	72,552 $1.95 Million
Q4 2020 Feb 08, 2021	BUY	$19.41 - $26.0 $329,970 - $442,000	17,000 Added 30.14%	73,403 $1.68 Million
Q2 2020 Aug 07, 2020	BUY	$5.2 - $29.12 $49,400 - $276,640	9,500 Added 20.25%	56,403 $1.58 Million
Q1 2020 May 06, 2020	SELL	$4.28 - $12.11 $6,634 - $18,770	-1,550 Reduced 3.2%	46,903 $273,000
Q4 2019 Feb 05, 2020	SELL	$7.95 - $12.27 $100,170 - $154,602	-12,600 Reduced 20.64%	48,453 $527,000
Q3 2019 Nov 07, 2019	BUY	$12.44 - $17.48 $22,640 - $31,813	1,820 Added 3.07%	61,053 $779,000
Q2 2019 Aug 09, 2019	BUY	$14.51 - $19.71 $157,143 - $213,459	10,830 Added 22.37%	59,233 $1.01 Million
Q1 2019 May 08, 2019	SELL	$11.11 - $25.6 $12,776 - $29,440	-1,150 Reduced 2.32%	48,403 $870,000
Q4 2018 Feb 08, 2019	SELL	$11.75 - $21.42 $75,787 - $138,159	-6,450 Reduced 11.52%	49,553 $629,000
Q3 2018 Nov 07, 2018	SELL	$19.26 - $23.46 $87,247 - $106,273	-4,530 Reduced 7.48%	56,003 $1.2 Million
Q2 2018 Aug 10, 2018	BUY	$19.78 - $24.67 $197,404 - $246,206	9,980 Added 19.74%	60,533 $1.25 Million
Q4 2017 Feb 13, 2018	BUY	$16.19 - $20.3 $270,729 - $339,456	16,722 Added 49.43%	50,553 $961,000
Q2 2017 Aug 11, 2017	BUY	N/A	33,831	33,831 $592,000

Others Institutions Holding MGNX

# of Institutions

129

Shares Held

55.7M

Call Options Held

28.3K

Put Options Held

197K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $99.6M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account

New York State Common Retirement Fund Macrogenics Inc Transaction History